Patient subgroups | ||||
---|---|---|---|---|
Characteristic | No enthesitis + no arthritis (n = 457) | Enthesitis + no arthritis (n = 512) | Arthritis + no enthesitis (n = 107) | Enthesitis + arthritis (n = 174) |
Age, years | 43.1 ± 11.2 | 42.7 ± 11.1 | 46.0 ± 11.9 | 46.1 ± 12.3 |
Males, percentage | 80.7 | 67.8 | 69.2 | 58.0 |
HLA-B27-positive, percentage | 83.7 | 82.2 | 84.1 | 76.0 |
AS duration, years | 10.9 ± 9.4 | 10.5 ± 9.7 | 12.3 ± 10.6 | 11.8 ± 10.5 |
Advanced AS, percentage | 25.2 | 28.4 | 27.6 | 26.5 |
Concomitant NSAIDs, percentage | 74.0 | 76.8 | 73.8 | 68.4 |
Concomitant DMARDs, percentage | 21.7 | 22.1 | 45.8 | 35.6 |
Concomitant glucocorticoidsa, percentage | 10.1 | 10.9 | 29.9 | 20.1 |
Prior TNF-antagonist therapy, percentage | 25.8 | 25.0 | 27.1 | 29.3 |